AOD9604 2AD 2mg*10vials

AOD9604 2AD 2mg x 10 Vials

Product Overview

AOD9604 2AD is a high-purity optimized freeze-dried lipolysis research peptide derived from a key truncated analog of human growth hormone hGH and modified with an upgraded 2AD molecule. Unlike traditional appetite-regulating metabolic peptides, AOD9604 2AD supports lipid metabolism activation precise targeting research, high targeted lipolysis efficiency, stable bioactivity, and low systemic irritation research. The 2mg low-precision formulation is designed for fine-gradient dose screening, lipolysis mechanism research, long-term continuous metabolic intervention, and biosafety validation experiments, serving as a core ingredient for preclinical lipid metabolism and adipose tissue remodeling research.

Core Research Functions

Unique Targeted Lipid Metabolism Regulatory Effect and Normal Endocrine Hormone Balance Related Studies: Supports unique targeted lipid metabolism regulatory effect research, normal endocrine hormone balance interference related studies.

Adipocyte Metabolic Pathways Primary Activation and Visceral Subcutaneous Adipose Tissue Breakdown Oxidation Acceleration: Supports adipocyte metabolic pathways primary activation research, visceral and subcutaneous adipose tissue breakdown oxidation acceleration studies, and adipocyte proliferation and lipid accumulation inhibition research.

GLP-1 Peptides Appetite Suppression Comparison and Lipid Metabolism Activation Fundamental Metabolism Regulation: Supports GLP-1 peptides that rely on appetite suppression comparison research, lipid metabolism activation fundamental metabolism regulation research, supporting obesity, abnormal lipid deposition, adipose browning remodeling, and lipid metabolism disorders correction in-depth research.

Optimized 2AD Molecular Structure Targeting Specificity Anti-Degradation Stability Enhancement: Supports optimized 2AD molecular structure targeting specificity and anti-degradation stability enhancement research, low 2mg dosage ultra-fine dose grouping and long-term repeated interventions enabling research.

High-Precision Low-Interference Reliable Mechanistic Data for Cutting-Edge Lipid Metabolism Research: Supports high-precision low-interference reliable mechanistic data provision research for cutting-edge lipid metabolism research.

AOD9604 2AD supports unique targeted lipid metabolism regulatory effect research, normal endocrine hormone balance interference related studies. In laboratory studies, AOD9604 2AD primarily supports adipocyte metabolic pathways activation research, visceral and subcutaneous adipose tissue breakdown oxidation acceleration studies, and adipocyte proliferation and lipid accumulation inhibition research. Unlike GLP-1 peptides that rely on appetite suppression, AOD9604 2AD supports lipid metabolism activation fundamental metabolism regulation research. The optimized 2AD molecular structure supports targeting specificity and anti-degradation stability enhancement research, while the low 2mg dosage supports ultra-fine dose grouping and long-term repeated interventions enabling research, providing high-precision low-interference reliable mechanistic data for cutting-edge lipid metabolism research.

Core Product Advantages

Optimized and Improved 2AD: The upgraded molecular structure supports lipid targeting affinity and in vivo stability improvement research, non-specific binding effective reduction research. Compared to ordinary AOD9604, it supports purer lipolytic activity and a more concentrated experimental phenotype research.

Precise 2mg Low-Dose Dosage: The professional low-concentration design is suitable for fine-dose gradient experiments, long-term continuous modeling, and biosafety testing, supporting excessive dosage caused experimental failures related avoidance research and metabolic thresholds precise exploration enabling research.

Unique Lipid Metabolism Mechanism: Supports independent lipolysis pathway research, appetite or normal hormone levels affecting related studies, achieving pure lipid metabolism intervention research, supporting targeted lipid regulation research technological gap filling research.

Pharmaceutical-Grade Freeze-Drying Process: Aseptic vacuum freeze-drying supports peptide activity stable retention research. Each batch undergoes rigorous HPLC purity testing and complete Certificate of Analysis COA certification, supporting ultra-low impurities and excellent batch repeatability research.

Standard 10-Vial Packaging: 10 vials per box, integrated aseptic packaging, suitable for long-term laboratory storage, university lipid metabolism research projects, and professional bulk wholesale purchases.

Specifications and Quality Control

Format: Lyophilized powder, 2mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis COA.